Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Liquid-level sensor with a high-birefringence-fiber loop mirror.

Bo D, Qida Z, Feng L, Tuan G, Lifang X, Shuhong L, Hong G.

Appl Opt. 2006 Oct 20;45(30):7767-71.

PMID:
17068507
2.

Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation.

Ciabatti R, Kettenring JK, Winters G, Tuan G, Zerilli L, Cavalleri B.

J Antibiot (Tokyo). 1989 Feb;42(2):254-67.

3.

Isolation and structure determination of the main related substances of teicoplanin, a glycopeptide antibiotic.

Cometti A, Gallo GG, Kettenring J, Panzone GB, Tuan G, Zerilli LF.

Farmaco Sci. 1988 Dec;43(12):1005-18.

PMID:
2977757
4.

Metabolic oxidation of the pyrrole ring: structure and origin of some urinary metabolites of the anti-hypertensive pyrrolylpyridazinamine, mopidralazine. III: Studies with the 13C-labelled drug.

Assandri A, Tarzia G, Bellasio E, Ciabatti R, Tuan G, Ferrari P, Zerilli L, Lanfranchi M, Pelizzi G.

Xenobiotica. 1987 May;17(5):559-73.

PMID:
3604261
5.

Identification of 5-hydroxypyrazinamide isolated from urine of subjects given pyrazinamide.

Beretta E, Botturi S, Ferrari P, Tuan G, Zerilli LF.

J Chromatogr. 1987 Apr 24;416(1):144-9. No abstract available.

PMID:
3597630
6.

Zetidoline metabolism by rat liver microsomes. Formation of metabolites with potential neuroleptic activity.

Assandri A, Galliani G, Zerilli L, Tuan G, Tarzia G, Barone D.

Biochem Pharmacol. 1986 May 1;35(9):1459-67.

PMID:
2871840
7.

Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. II: Studies in the dog.

Assandri A, Perazzi A, Bellasio E, Ciabatti R, Tarzia G, Ferrari P, Ripamonti A, Tuan G, Zerilli LF.

Xenobiotica. 1985 Dec;15(12):1089-102.

PMID:
4090528
8.

Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine+ ++ hydrochloride. I. Studies in the rat.

Assandri A, Perazzi A, Baldoli E, Ferrari P, Ripamonti A, Bellasio E, Tuan G, Zerilli F, Tarzia G.

Xenobiotica. 1985 Dec;15(12):1069-87.

PMID:
4090527
9.

Metabolic fate of zetidoline, a new neuroleptic agent, in man.

Assandri A, Perazzi A, Ferrari P, Martinelli E, Ripamonti A, Tarzia G, Tuan G.

Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):341-7.

PMID:
2858825
10.

Metabolism of the neuroleptic agent zetidoline in the rat and the dog.

Assandri A, Perazzi A, Fontanella L, Ferrari P, Ripamonti A, Tarzia G, Tuan G, Martinelli E.

Drug Metab Dispos. 1984 Sep-Oct;12(5):635-40.

PMID:
6149917
11.

Metabolic pathways of the contragestational agent, 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole (DL 111-IT), in the rat.

Assandri A, Perazzi A, Ferrari P, Omodei-Salé A, Ripamonti A, Tuan G, Galliani G, Zerilli LF.

Xenobiotica. 1984 Jun;14(6):429-43.

PMID:
6475103
12.

Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. V. Aromatic constituents.

Coronelli C, Bardone MR, DePaoli A, Ferrari P, Tuan G, Gallo GG.

J Antibiot (Tokyo). 1984 Jun;37(6):621-6.

13.

Metabolic fate of premazepam, a new anti-anxiety drug, in the rat and the dog.

Assandri A, Barone D, Ferrari P, Perazzi A, Ripamonti A, Tuan G, Zerilli LF.

Drug Metab Dispos. 1984 Mar-Apr;12(2):257-63.

PMID:
6144494
14.
15.

Disposition and metabolism of a new steroidal anti-inflammatory agent, deflazacort, in cynomolgus monkeys.

Assandri A, Ferrari P, Perazzi A, Ripamonti A, Tuan G, Zerilli L.

Xenobiotica. 1983 Mar;13(3):185-96.

PMID:
6613164
16.

Species differences in the disposition and metabolism of 1-methyl-3-(3-pyridyl)-5-(2-hydroxy-methylphenyl)-1H-1,2,4-triazole, a potential sedative-hypnotic compound.

Assandri A, Omodei-Salè A, Ferrari P, Tuan G, Perazzi A, Ripamonti A, Martinelli E.

Xenobiotica. 1982 Jan;12(1):19-30.

PMID:
7090416
17.

Rifamycin Z, a novel ansamycin from a mutant of Nocardia mediterranea.

Cricchio R, Antonini P, Ferrari P, Ripamonti A, Tuan G, Martinelli E.

J Antibiot (Tokyo). 1981 Oct;34(10):1257-60. No abstract available.

18.

Influence of metabolism on the activity of a new anti-fertility agent, 2-(3-ethoxyphenyl)-5,6-dihydro-s-triazolo [5,1-a]isoquinoline (DL 204-IT), in the rat and the hamster.

Assandri A, Perazzi A, Martinelli E, Ferrari P, Ripamonti A, Tuan G, Galliani G.

Arzneimittelforschung. 1981;31(12):2104-11.

PMID:
7199307
19.

Metabolism of deflazacort in the rat, dog and man.

Martinelli E, Ferrari P, Ripamonti A, Tuan G, Perazzi A, Assandri A.

Drug Metab Dispos. 1979 Sep-Oct;7(5):335-9.

PMID:
40777
20.

Metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine dihydrochloride in rat urine.

Beretta E, Cristina T, Ferrari P, Tuan G, Zerilli LF, Martinelli E.

Eur J Drug Metab Pharmacokinet. 1979;4(1):29-33.

PMID:
38122
21.

The reaction of phthalazino(2,3-b)phthalazine-5,12(7H, 14H)-diones with nitrous acid.

Bellasio E, Tuan G.

Farmaco Sci. 1975 May;30(5):343-52.

PMID:
1175761

Supplemental Content

Support Center